● Recruiting

Study of Daraxonrasib and Daraxonrasib + GnP as First-line Treatment in Patients With Metastatic Pancreatic Adenocarcinoma

Condition: Pancreatic Cancer · Pancreatic Cancer Metastatic · PDAC · Sponsor: Revolution Medicines, Inc.

PhasePhase 3

Planned participants900

Who can joinAll sexes, 18 Years to no upper limit

Healthy volunteersNo

About this study

The purpose of this study is to evaluate the safety and efficacy of an investigational RAS(ON) inhibitor administered as monotherapy or in combination with chemotherapy, compared with standard of care (SOC) chemotherapy alone.

This description comes directly from the study's public registry record.

Talk to the study team

Revolution Medicines Study Director · 1-844-2-REVMED · medinfo@revmed.com

Always discuss trial participation with your own doctor first.

Locations (20)

Honor Health Research Institute	Scottsdale, Arizona, United States	Recruiting
H Lee Moffitt Cancer Center and Research Institute	Tampa, Florida, United States	Recruiting
Johns Hopkins Sidney Kimmel Comprehensive Cancer Center	Baltimore, Maryland, United States	Recruiting
Dana-Farber Cancer Institute	Boston, Massachusetts, United States	Recruiting
Comprehensive Cancer Centers of Nevada	Henderson, Nevada, United States	Recruiting
Memorial Sloan Kettering Cancer Center	New York, New York, United States	Recruiting
University of Cincinnati Cancer Center	Cincinnati, Ohio, United States	Recruiting
Taylor Cancer Research Center	Maumee, Ohio, United States	Recruiting
SCRI Oncology Partners	Nashville, Tennessee, United States	Recruiting
SCRI - Texas Oncology Dallas	Dallas, Texas, United States	Recruiting
MD Anderson Cancer Center	Houston, Texas, United States	Recruiting
Virginia Cancer Specialists	Fairfax, Virginia, United States	Recruiting

+ 8 more locations — full list on the registry record.

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07491445